Omega Fund Management, LLC Gossamer Bio, Inc. Transaction History

Omega Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.97 - $9.97 $9.94 Million - $16.6 Million	-1,664,835 Reduced 52.6%	1,500,000 $12.6 Million
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $1.58 Million - $2.19 Million	-155,773 Reduced 4.69%	3,164,835 $35.8 Million
Q2 2020 Aug 17, 2020	SELL	$9.52 - $15.98 $9.09 Million - $15.3 Million	-955,118 Reduced 22.34%	3,320,608 $43.2 Million
Q1 2020 May 14, 2020	SELL	$8.0 - $15.48 $14.7 Million - $28.5 Million	-1,843,619 Reduced 30.13%	4,275,726 $43.4 Million
Q4 2019 Feb 13, 2020	SELL	$14.82 - $26.79 $6.43 Million - $11.6 Million	-433,771 Reduced 6.62%	6,119,345 $95.6 Million
Q3 2019 Nov 13, 2019	SELL	$16.02 - $22.47 $6.41 Million - $8.99 Million	-400,300 Reduced 5.76%	6,553,116 $110 Million
Q1 2019 May 20, 2019	BUY	$17.58 - $23.97 $122 Million - $167 Million	6,953,416 New	6,953,416 $151 Million

109

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $83.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Omega Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Omega Fund Management, LLC with notifications on news.